Sofosbuvir L-alanitate (Mixture of Diasteriomers) | CAS 1064684-44-1 - 请求报价
化学名称 :
运输温度 :
HSN编码 :
原产国 :
微笑 :
使用说明:
Sofosbuvir L-alanitate (Mixture of Diasteriomers) is chemically (2S)-Isopropyl 2-(((((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate. Sofosbuvir L-alanitate (Mixture of Diasteriomers) is supplied with detailed characterization data compliant with regulatory guideline. Sofosbuvir L-alanitate (Mixture of Diasteriomers) can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sofosbuvir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
应用与法规使用场景
购买 1064684-44-1
采购 1064684-44-1
订购 1064684-44-1
询问 1064684-44-1
price of 1064684-44-1
1064684-44-1 供应商
1064684-44-1 制造商
1064684-44-1 出口商
buy high quality Sofosbuvir L-alanitate (Mixture of Diasteriomers)
采购 Sofosbuvir L-alanitate (Mixture of Diasteriomers)
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 供应商
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 制造商
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 价格
订购 Sofosbuvir L-alanitate (Mixture of Diasteriomers)
询问 Sofosbuvir L-alanitate (Mixture of Diasteriomers)
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 成本
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 供应商
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 分销商
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 用于方法验证
Sofosbuvir 对照标准
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 用于ANDA申报
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 用于强制降解研究
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 鉴别标准
Sofosbuvir L-alanitate (Mixture of Diasteriomers) 用于DMF申报
相关产品
免责声明
SynZeal 在本网站上提供的产品信息是根据发布时的现有理解而提供的。客户在实际购买时有责任评估信息的准确性。
SynZeal 将根据产品规格的新发展或新发现更新这些详细信息，恕不另行通知。